Atlas Trials

A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjects

Clinical trial NCT06669429 · RECRUITING

Trial details

NCT number
NCT06669429
Sponsor
Peking University First Hospital
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2024-09-25
Primary completion
2025-06-30
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.